Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$7.96 - $13.59 $79,647 - $135,981
10,006 New
10,006 $84,000
Q4 2023

Feb 12, 2024

SELL
$14.18 - $22.31 $18,887 - $29,716
-1,332 Reduced 12.26%
9,535 $205,000
Q3 2023

Nov 08, 2023

SELL
$18.22 - $25.85 $58,486 - $82,978
-3,210 Reduced 22.8%
10,867 $208,000
Q2 2023

Aug 14, 2023

BUY
$22.62 - $39.32 $3,438 - $5,976
152 Added 1.09%
14,077 $357,000
Q1 2023

May 11, 2023

BUY
$30.17 - $41.11 $4,495 - $6,125
149 Added 1.08%
13,925 $503,000
Q4 2022

Feb 08, 2023

SELL
$36.43 - $49.4 $163,169 - $221,262
-4,479 Reduced 24.54%
13,776 $545,000
Q3 2022

Nov 09, 2022

BUY
$40.66 - $53.03 $20,492 - $26,727
504 Added 2.84%
18,255 $851,000
Q2 2022

Aug 10, 2022

BUY
$40.85 - $77.67 $4,983 - $9,475
122 Added 0.69%
17,751 $779,000
Q1 2022

May 12, 2022

BUY
$59.95 - $92.06 $143,340 - $220,115
2,391 Added 15.69%
17,629 $1.28 Million
Q4 2021

Feb 10, 2022

BUY
$81.07 - $121.29 $393,919 - $589,348
4,859 Added 46.82%
15,238 $1.24 Million
Q3 2021

Nov 12, 2021

BUY
$101.99 - $166.36 $10,199 - $16,636
100 Added 0.97%
10,379 $1.21 Million
Q2 2021

Aug 06, 2021

SELL
$141.6 - $179.06 $7,080 - $8,953
-50 Reduced 0.48%
10,279 $1.7 Million
Q1 2021

May 10, 2021

SELL
$132.81 - $182.18 $589,676 - $808,879
-4,440 Reduced 30.06%
10,329 $1.44 Million
Q4 2020

Feb 10, 2021

SELL
$138.17 - $184.34 $118,826 - $158,532
-860 Reduced 5.5%
14,769 $2.56 Million
Q3 2020

Nov 13, 2020

BUY
$114.09 - $145.51 $309,868 - $395,205
2,716 Added 21.03%
15,629 $2.18 Million
Q2 2020

Aug 10, 2020

SELL
$89.45 - $129.85 $525,518 - $762,868
-5,875 Reduced 31.27%
12,913 $1.54 Million
Q1 2020

May 21, 2020

BUY
$70.23 - $144.31 $249,667 - $513,022
3,555 Added 23.34%
18,788 $1.88 Million
Q4 2019

Feb 14, 2020

BUY
$76.41 - $117.54 $126,076 - $193,941
1,650 Added 12.15%
15,233 $1.79 Million
Q3 2019

Nov 12, 2019

BUY
$61.52 - $91.1 $278,378 - $412,227
4,525 Added 49.96%
13,583 $1.17 Million
Q2 2019

Aug 13, 2019

BUY
$58.04 - $66.99 $525,726 - $606,795
9,058 New
9,058 $587,000

Others Institutions Holding NVRO

About NEVRO CORP


  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $133M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.